Literature DB >> 27889671

European Journal of Cancer's Biennial report on soft tissue and visceral sarcomas or the rapid evolution of treatment concepts in sarcomas.

Jean-Yves Blay1, Mehdi Brahmi2, Isabelle Ray-Coquard2.   

Abstract

Soft tissue and visceral sarcoma gather a large group of rare to very rare cancers and locally aggressive connective tissue tumours. Novel concepts on histological and molecular classification, optimal management of patients, systemic adjuvant and neoadjuvant treatment have been emerging in the last 5 years. In the present publication, we review and summarise significant changes which impact on disease management in this group of rare cancers.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Adjuvant; Expert centres; Molecular classification; Neoadjuvant; Network; Sarcoma; Surgery; Targeted therapies

Mesh:

Substances:

Year:  2016        PMID: 27889671     DOI: 10.1016/j.ejca.2016.07.028

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  2 in total

1.  Making the right calls in precision oncology.

Authors:  Kathryn D Bungartz; Kristen Lalowski; Sheryl K Elkin
Journal:  Nat Biotechnol       Date:  2018-08-06       Impact factor: 54.908

2.  [Locoregional hyperthermia improves disease-specific overall survival in combination with neoadjuvant chemotherapy in high-risk soft tissue sarcomas].

Authors:  Franziska Eckert; Daniel Zips
Journal:  Strahlenther Onkol       Date:  2018-08       Impact factor: 3.621

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.